• PP 2 (AG 1879) for Src Signaling Research

  2026-08-31

  PP 2 (AG 1879) provides a practical chemical probe for separating Src-family kinase signaling from downstream calcium and oxidative-stress mechanisms. This workflow-focused guide connects cancer and immune assays with vascular pharmacology, emphasizing controls, solubility, and interpretation limits.

• Dabigatran Etexilate: Oral Direct Thrombin Inhibition

  2026-08-31

  The reference review presents dabigatran etexilate as the first marketed oral direct thrombin inhibitor in the United States, emphasizing its rapid, predictable anticoagulant activity and reduced dependence on routine INR monitoring. Its prodrug activation through carboxylesterases, lack of CYP450 involvement, renal clearance considerations, and clinical evidence across thromboembolic indications define both its practical value and its interaction-study implications.

• ALDH2 Activation Delays Pressure-Overload Heart Failure

  2026-08-30

  The reference study identifies ALDH2 as more than a mitochondrial aldehyde-detoxification enzyme: its activation also preserves cardiomyocyte proliferative capacity and delays pressure overload-induced heart failure in mice. By combining neonatal cardiomyocyte experiments with an adult transverse aortic constriction model, the work connects ALDH2 activity to cardiac regeneration and provides a framework for testing pharmacological activation in cardiac disease research.

• Radicicol: From Hsp90 Inhibition to Translation

  2026-08-29

  A mechanistic and translational framework for using Radicicol across Hsp90, PDK3, adipogenesis, ovarian carcinoma apoptosis, and sepsis inflammation studies—while preserving assay rigor and biological interpretation.

• FITC Goat Anti-Mouse IgG: From Signal to Biology

  2026-08-28

  Learn how the FITC Goat Anti-Mouse IgG (H+L) Antibody converts mouse-primary-antibody binding into interpretable fluorescence, from MAVS pathway studies to assay design. This article connects secondary-antibody chemistry with controls, imaging strategy, and mechanistic confidence.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-28

  This study identifies Kupffer cell TMEM16F as a key determinant of host protection during Listeria monocytogenes infection. By combining cell type-specific knockout mice with plasma-membrane repair, inflammation, and liver-metabolism analyses, the authors show that TMEM16F limits Kupffer cell rupture and prevents secondary hepatic injury.

• Guanabenz Acetate: From GPCRs to Immune Signaling

  2026-08-27

  A translational framework for using Guanabenz Acetate to connect α2-adrenergic receptor pharmacology with stress-granule and innate immune research—without confusing a mechanistic hypothesis with an antiviral claim.

• Sildenafil Citrate for Proteoform-Aware Vascular Research

  2026-08-27

  Sildenafil Citrate connects cGMP pathway perturbation with practical studies of vascular smooth muscle, ERK signaling, and proteoform-dependent drug interactions. This workflow-focused guide shows how to use the compound in cell assays, tissue models, and native mass spectrometry while controlling solubility, timing, selectivity, and off-target interpretation.

• Angiotensin I: From Precursor to Translation

  2026-08-26

  Angiotensin I is more than an inactive intermediate: it is a defined substrate for resolving renin–angiotensin system control, ACE activity, cardiovascular signaling, neuroendocrine responses, and emerging peptide-dependent receptor-binding questions. This thought-leadership guide connects mechanism, assay design, product selection, and translational decision-making.

• Prion Self-Assembly Tunes Mutagenesis for Adaptation

  2026-08-26

  The reference study identifies prion-based protein self-assembly as a heritable yet reversible regulator of DNA repair, recombination, and mutagenesis in yeast. By combining functional genomics, cell biology, and massively parallel evolution, it shows how protein-state inheritance can redirect adaptation and accelerate antifungal drug resistance.

• EZ Cap™ Human PTEN mRNA: Research Guide

  2026-08-25

  EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA reagent designed for transient human PTEN expression in mammalian research systems. Its Cap 1 structure, pseudouridine triphosphate, and poly(A) tail support translation-focused experiments involving mRNA stability enhancement, PI3K/Akt signaling pathway inhibition, and cancer research.

• Hydroxytyrosol Workflows for Cardiovascular Research

  2026-08-25

  Build reproducible cell-based assays around Hydroxytyrosol for oxidative stress modulation, inflammatory profiling, and cholesterol-efflux studies. This workflow distinguishes pure compound testing from olive oil extract comparisons and provides practical starting conditions for optimization.

• Lanabecestat (AZD3293) BACE1 Research Workflow

  2026-08-24

  Build a translational Alzheimer’s disease research workflow around Lanabecestat (AZD3293), linking amyloid-beta reduction to synaptic-function readouts rather than relying on a single endpoint. Practical dosing, sample-handling, and troubleshooting guidance helps researchers distinguish useful partial BACE1 inhibition from exposure levels that may disrupt neuronal physiology.

• Machine Learning Prediction of mRNA Lipid Nanoparticles

  2026-08-24

  The 2022 Acta Pharmaceutica Sinica B study developed a LightGBM model that predicted the performance of lipid nanoparticle formulations for mRNA vaccines from 325 formulation samples. Its value lies in combining data-driven formulation screening with animal validation and molecular dynamics, showing how computational prioritization can reduce reliance on empirical ionizable-lipid screening.

• RQ3025: Broad-Spectrum Bivalent mRNA Vaccine Evidence

  2026-08-23

  Lu et al. evaluated RQ3025, a bivalent mRNA vaccine engineered to incorporate spike mutations associated with SARS-CoV-2 evolution. Across several animal models, the candidate induced broad neutralizing activity, protected vaccinated rats against emerging variants, promoted a Th1-biased response, and showed no detected organ pathology after high-dose administration.

7878 records 1/526 page Next 12345 下5页 Last page